Canada markets open in 2 hours 49 minutes

Psyched Wellness Ltd. (PSYCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0871+0.0041 (+5.00%)
At close: 03:49PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.0830
Open0.0815
BidN/A x N/A
AskN/A x N/A
Day's Range0.0792 - 0.0881
52 Week Range0.0740 - 0.5940
Volume39,140
Avg. Volume108,591
Market Cap11.325M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    The Power Play by The Market Herald Releases Interviews With Xali Gold, Falcon Gold, Psyched Wellness, Argentina Lithium, and Algernon Pharmaceuticals

    VANCOUVER, BC / ACCESSWIRE / January 19, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Xali Gold, Falcon Gold, Psyched Wellness, Argentina Lithium, and Algernon Pharmaceuticals discussing their latest press releases.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

  • Newsfile

    Psyched Wellness Announces Vantage Hemp Co. as Contract Manufacturing Organization Partner to Bring AME-1-derived Products to Market

    Canadian brand leading the emerging functional food category partners with industry-leading extraction and manufacturing partner based in Greeley, Colorado Toronto, Ontario--(Newsfile Corp. - January 18, 2022) - Psyched Wellness Ltd., (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce Vantage Hemp Co. as the Company's contract manufacturing

  • Newsfile

    Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA

    Toronto, Ontario--(Newsfile Corp. - December 16, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it is moving forward with its regulatory strategy to launch its Amanita Muscaria extract ("AME-1")-derived consumer products in-stores in the United States market in the second quarter of 2022.To achieve thi